Cargando…

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer

Cancer immunotherapy has been heralded as a breakthrough cancer treatment demonstrating tremendous success in improving tumor responses and survival of patients with hematological cancers and solid tumors. This novel promising treatment approach has in particular triggered optimism for triple negati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naik, Adviti, Monjazeb, Arta Monir, Decock, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703078/ https://www.ncbi.nlm.nih.gov/pubmed/31475003 http://dx.doi.org/10.3389/fimmu.2019.01940

Ejemplares similares

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
por: Naik, Adviti, et al.
Publicado: (2020)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
por: Naik, Adviti, et al.
Publicado: (2022)

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
por: Naik, Adviti, et al.
Publicado: (2021)

Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the “obesity paradox”
por: Vick, Logan V., et al.
Publicado: (2023)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
por: Thomas, Remy, et al.
Publicado: (2020)

Gut Microbiota and the Paradox of Cancer Immunotherapy
por: Poutahidis, Theofilos, et al.
Publicado: (2014)

The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
por: Zhao, Qing, et al.
Publicado: (2022)

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Exploration of Novel Immunological Terms in Lung Cancer With Large Populations: Implications for Immunotherapy
por: Yao, Yuanshan, et al.
Publicado: (2022)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Paradox-driven adventures in the development of cancer immunology and immunotherapy
por: Barham, Whitney, et al.
Publicado: (2019)

Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
por: Fidelle, Marine, et al.
Publicado: (2020)

Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer
por: Fang, Kun, et al.
Publicado: (2022)

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
por: Thomas, Remy, et al.
Publicado: (2018)

HIV As Trojan Exosome: Immunological Paradox Explained?
por: Hildreth, James E. K.
Publicado: (2017)

Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
por: Huang, Pengfei, et al.
Publicado: (2023)

Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
por: Karan, Dev
Publicado: (2018)

Editorial: Decoding immunologic complex systems in cancer: the cutting-edge technologies revolutionizing cancer immunology and immunotherapy
por: Li, Hu, et al.
Publicado: (2023)

Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy
por: de Alencar, Viviane Teixeira L., et al.
Publicado: (2022)

Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice
por: Khuat, Lam T., et al.
Publicado: (2021)

Editorial: Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy
por: Caserta, Stefano, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
por: Thomas, Remy, et al.
Publicado: (2021)

Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy
por: Lin, Liangbin, et al.
Publicado: (2019)

Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy
por: Bracci, Laura, et al.
Publicado: (2020)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Roles and therapeutic implications of m6A modification in cancer immunotherapy
por: Pan, Juan, et al.
Publicado: (2023)

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
por: Cao, Xu, et al.
Publicado: (2021)

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
por: Pérez-Pena, Javier, et al.
Publicado: (2019)

Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
por: Chen, Yu, et al.
Publicado: (2022)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

Ferroptosis: the emerging player in remodeling triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2023)

Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m5prq75f8clgvn514r7rb0b856